Streetbeat News

Partnerships

CODA

Coda Octopus Group, Inc. (CODA) announced the launch of Voice HUB-4, an AI-based digital audio communications system, following successful tests with Naval customers. This new technology, which supports up to four divers and includes features like Digital Noise Removal and Helium Speech Descrambling, represents a significant advancement over traditional underwater analogue audio communications. Developed in conjunction with the US Navy, Voice HUB-4 aims to improve safety and clarity in underwater communications for divers.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 12:15 pm

MSFT

The Financial Times has entered into a content licensing agreement with OpenAI, allowing the AI firm to train its models on FT's content. This partnership aims to enhance OpenAI's ChatGPT with FT's attributed content and develop new AI products for FT readers. Financial terms were not disclosed. OpenAI, backed by Microsoft (MSFT), previously secured a similar deal with the Associated Press. The collaboration will enable ChatGPT to use select FT content summaries, quotes, and links in its responses.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 12:12 pm

SEEL

Seelos Therapeutics, Inc. (NASDAQ:SEEL) announced a strategic focus on mental health initiatives, including updates on potential partnerships and collaborations. Richard Pascoe has been appointed as Chairman of the Board to lead these efforts. The company is in discussions for a potential collaboration in the mental health space, leveraging its ketamine expertise with SLS-002 for suicidality and involvement in a PTSD study. Seelos aims to create a leading mental health company and increase shareholder value but will not comment further until a decision is made.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 12:11 pm

ARQQ

Arqit Quantum's stock price increased following the announcement of its partnership with Intel to launch Quantum-Safe, 1.89 Tb IPsec products.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:29 am

IYE

XLE

XOM

Exxon Mobil Corporation (NYSE:XOM) is in talks with Turkey for a multibillion-dollar LNG deal to help Turkey reduce its reliance on Russian natural gas. Turkey aims to secure up to 2.5 million tonnes of LNG annually from Exxon, which could cost about $1.1 billion and cover 7% of its consumption. Exxon is expanding its LNG portfolio and recently reported first-quarter revenue of $83.083 billion. Investors can also gain exposure to XOM through Energy Select Sector SPDR Fund (NYSE:XLE) and iShares U.S. Energy ETF (NYSE:IYE).

Portfolio Pulse from Lekha Gupta

April 29, 2024 | 11:27 am

MRNA

Moderna has entered a non-exclusive out-licensing agreement for its COVID-19-related patents in Japan, securing an upfront payment and a low double-digit royalty on net sales of its COVID-19 product. Financial terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:18 am

BIDU

TSLA

Tesla, Inc. (TSLA) shares surged about 10% in premarket trading following CEO Elon Musk's successful visit to China, where he reportedly secured approval for full-self driving (FSD) in the country. Musk's discussions with Premier Li Qiang and other officials, along with a potential partnership with Baidu, Inc. (BIDU) for mapping and navigation, are seen as pivotal for Tesla's expansion in China. Analyst Daniel Ives from Wedbush views this development as a watershed moment for Tesla, maintaining an Overweight rating and a $275 price target for TSLA stock.

Portfolio Pulse from Shanthi Rexaline

April 29, 2024 | 11:14 am

ARQQ

INTC

Arqit Quantum Inc. has partnered with Intel to launch the world's first quantum-safe 1.89 Tb IPsec products, utilizing Arqit's Symmetric Key Agreement Platform on Intel Xeon Scalable processors. This collaboration aims to provide high-performance encryption solutions that guard against quantum attacks, with financial terms not disclosed.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:08 am

TECH

TMO

Bio-Techne will partner with Thermo Fisher Scientific for the distribution of its products across Europe starting May 1, 2024. This agreement enables Thermo Fisher to distribute Bio-Techne's portfolio, including antibodies, proteins, and reagents, through its Fisher Scientific Channel in Europe.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:07 am

LH

PFE

The FDA has approved Labcorp's nAbCyte Anti-AAVRh74var HB-FE, a companion diagnostic for determining patient eligibility for Beqvez, Pfizer's FDA-approved gene therapy for Hemophilia B. This marks a significant advancement in personalized medicine for Hemophilia B treatment.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:04 am